Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein

被引:378
作者
Ng, CJ [1 ]
Wadleigh, DJ [1 ]
Gangopadhyay, A [1 ]
Hama, S [1 ]
Grijalva, VR [1 ]
Navab, M [1 ]
Fogelman, AM [1 ]
Reddy, ST [1 ]
机构
[1] Univ Calif Los Angeles, Dept Med, Atherosclerosis Res Unit, Los Angeles, CA 90095 USA
关键词
D O I
10.1074/jbc.M105660200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The oxidation of apolipoprotein B-containing lipoproteins and cell membrane lipids is believed to play an integral role in the development of fatty streak lesions, an initial step in atherogenesis. We have previously shown that two antioxidant-like enzymes, paraoxonase (PON)-1 and PON3, are high density lipoprotein-associated proteins capable of preventing the oxidative modification of low density lipoprotein (LDL) (Reddy, S. T., Wadleigh, D. J., Grijalva, V., Ng, C., Hama, S., Gango-padhyay, A., Shih, D. M., Lusis, A. J., Navab, M., and Fogelman, A. M. (2001) Arterioscler. Thromb. Vase. Biol. 21, 542-547). In the present study, we demonstrate that PON2 (i) is not associated with high density lipoprotein; (ii) has antioxidant properties; and (iii) prevents LDL lipid peroxidation, reverses the oxidation of mildly oxidized LDL (MM-LDL), and inhibits the ability of MM-LDL to induce monocyte chemotaxis. The PON2 protein was overexpressed in HeLa cells using the tetracycline-inducible ("Tet-On") system, and its antioxidant capacity was measured in a fluorometric assay. Cells that overexpressed PON2 showed significantly less intracellular oxidative stress following treatment with hydrogen peroxide or oxidized phospholipid. Moreover, cells that overexpressed PON2 were also less effective in oxidizing and modifying LDL and, in fact, were able to reverse the effects of preformed MM-LDL. Our results suggest that PON2 possesses antioxidant properties similar to those of PON1 and PON3. However, in contrast to PON1 and PON3, PON2 may exert its antioxidant functions at the cellular level, joining the host of intracellular antioxidant enzymes that protect cells from oxidative stress.
引用
收藏
页码:44444 / 44449
页数:6
相关论文
共 34 条
  • [1] A SPECTROPHOTOMETRIC MICROTITER-BASED ASSAY FOR THE DETECTION OF HYDROPEROXY DERIVATIVES OF LINOLEIC-ACID
    AUERBACH, BJ
    KIELY, JS
    CORNICELLI, JA
    [J]. ANALYTICAL BIOCHEMISTRY, 1992, 201 (02) : 375 - 380
  • [2] Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities - Selective action of human paraoxonase allozymes Q and R
    Aviram, M
    Billecke, S
    Sorenson, R
    Bisgaier, C
    Newton, R
    Rosenblat, M
    Erogul, J
    Hsu, C
    Dunlop, C
    La Du, B
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (10) : 1617 - 1624
  • [3] Genetic variation in paraoxonase-1 and paraoxonase-2 is associated with variation in plasma lipoproteins in Alberta Hutterites
    Boright, AP
    Connelly, PW
    Brunt, JH
    Scherer, SW
    Tsui, LC
    Hegele, RA
    [J]. ATHEROSCLEROSIS, 1998, 139 (01) : 131 - 136
  • [4] Association of PON2 variation with birth weight in Trinidadian neonates of South Asian ancestry
    Busch, CP
    Ramdath, DD
    Ramsewak, S
    Hegele, RA
    [J]. PHARMACOGENETICS, 1999, 9 (03): : 351 - 356
  • [5] Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation
    Draganov, DI
    Stetson, PL
    Watson, CE
    Billecke, SS
    La Du, BN
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (43) : 33435 - 33442
  • [6] DURRINGTON RN, 2001, ARTERIOSCLEROSIS, V21, P473
  • [7] Association between PON1 L/M55 polymorphism and plasma lipoproteins in two Canadian aboriginal populations
    Fanella, S
    Harris, SB
    Young, TH
    Hanley, AJG
    Zinman, B
    Connelly, PW
    Hegele, RA
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2000, 38 (05) : 413 - 420
  • [8] FOGELMAN AM, 1988, J LIPID RES, V29, P1243
  • [9] DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM
    HAVEL, RJ
    EDER, HA
    BRAGDON, JH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1955, 34 (09) : 1345 - 1353
  • [10] Hegele RA, 1998, CLIN GENET, V54, P394